Company Overview
| Stock Name | 杭州啟明醫療器械股份有限公司 - B - Ｈ股 |
|---|---|
| Stock Code | 02500 |
| Company Full Name | 杭州啟明醫療器械股份有限公司 - B - Ｈ股 |
| Industry | 醫療保健 |
| Principal Activities | 主要從事研發、生產及銷售治療心臟瓣膜疾病的醫療器械。 |
| Listing Date | 2019-12-10 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市濱江區江陵路88號2幢3樓311室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.venusmedtech.com/ |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 33.00 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 39.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 1,295,877,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 43.05 |
|---|---|
| First Day Open | HK$ 40.0 |
| First Day Change | 30.45% |
| First Day Volume | 53035200.0 |
| First Day Turnover | 2107270000.0 |
Use of Proceeds
| Use of Proceeds | 1、35.0%或約843.9百萬港元分配至我們的核心產品； 2、30.0%或約723.3百萬港元分配至我們的其他產品及在研產品； 3、10.0%所得款項凈額或約241.1百萬港元，為有關收購Keystone的代價付款及其他交易開支提供資金； 4、15.0%所得款項凈額或約361.7百萬港元，為我們透過內部研究及/或潛在收購持續擴充產品組合提供資金； 5、10.0%所得款項凈額或約241.1百萬港元，作營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (4)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
Credit Suisse (Hong Kong) Limited CE AAO017
招商证券（香港）有限公司 CE AAI650
Overall Coordinators (6)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
Credit Suisse (Hong Kong) Limited CE AAO017
招商证券（香港）有限公司 CE AAI650
招银国际融资有限公司 CE AVM940
海通国际证券有限公司 CE AAF806
Joint Bookrunners (9)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
Credit Suisse (Hong Kong) Limited CE AAO017
招商证券（香港）有限公司 CE AAI650
招银国际融资有限公司 CE AVM940
海通国际证券有限公司 CE AAF806
中银国际亚洲有限公司 CE AET863
农银国际融资有限公司 CE AWL249
香港上海汇丰银行有限公司
Joint Lead Managers (9)
高盛（亚洲）有限责任公司 CE ACC536
中国国际金融香港证券有限公司 CE AEN894
Credit Suisse (Hong Kong) Limited CE AAO017
招商证券（香港）有限公司 CE AAI650
招银国际融资有限公司 CE AVM940
海通国际证券有限公司 CE AAF806
中银国际亚洲有限公司 CE AET863
农银国际证券有限公司 CE ACX411
香港上海汇丰银行有限公司
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Aspex Master Fund | 156,519,000 HKD | — | 6.04% | — | 6 months | 2020-06-10 |
| 2 | Cephei QFII China Total Return Fund Ltd. | 156,519,000 HKD | — | 6.04% | — | 6 months | 2020-06-10 |
| 3 | China Alpha Funds | 78,259,500 HKD | — | 3.02% | — | 6 months | 2020-06-10 |
| 4 | GIC Private Limited | 234,778,500 HKD | — | 9.06% | — | 6 months | 2020-06-10 |
| 5 | Hillhouse Funds | 391,297,500 HKD | — | 15.10% | — | 6 months | 2020-06-10 |
Directors & Management
| Chairman | 胡定旭 |
|---|---|
| Company Secretary | 葉翠媚 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Qiming GP III, L.P.(13.33%);訾振軍(11.90%);曾敏(9.74%) |
|---|
